US EditionNew malaria vaccine approved by World Health Organization
- The World Health Organization has recommended the use of a cheap malaria vaccine developed by the University of Oxford, which is the second malaria vaccine to be developed.
- The R21 vaccine is 75% effective at preventing malaria in seasonal areas and is easier to manufacture and distribute than the previous vaccine.
- The rollout of both the R21 and RTS,S vaccines is expected next year, providing a vital additional tool in the fight against malaria.
67 Articles
67 Articles
WHO authorizes second malaria vaccine for children
“Well, I think this is great news. We still have a major challenge with malaria, with over 220 million cases and around 600,000 deaths a year. And those are, the majority of those are occurring in children under the age of five in sub-Saharan Africa..." Professor Azra Ghani
The World Health Organization has recommended a second malaria vaccine for children in affected regions.
The World Health Organization (WHO) on Monday recommended a second vaccine to prevent malaria, a dangerous disease spread by some mosquitoes, Reuters reports.
About 500,000 children die each year from malaria. The WHO has now recommended a second vaccine against tropical disease for children. It only costs around four dollars and, according to studies, is very effective. [more]
Cheap malaria vaccine to be rolled out at scale in bid to save thousands
A cheap malaria vaccine has been recommended for use by the World Health Organisation.The announcement supporting the jab developed by the University of Oxford could save thousands of lives.It is also only the second malaria vaccine to be developed.Malaria is particularly fatal for babies and infants.The scientific effort to tackle the scourge of malaria has been a long one.The disease, which is spread by bites from mosquitoes, is hidden from th…
Coverage Details
Bias Distribution
- 46% of the sources are Center
To view factuality data please Upgrade to Premium
